Hepcinat LP Tablets Supplier

What is Hepcinat-LP?
Hepcinat-LP is a tablet containing two antiviral drugs (Ledipasvir and Sofosbuvir) that together work as a direct-acting antiviral agent that interferes with hepatitis C virus (HCV) replication. This is used to treat patients who have contracted genotype 1 HCV (the most common subtype in the US and the UK).

How is Hepcinat-LP used?

• Each pack of Hepcinat-LP contains 28 tablets, with each tablet containing Ledipasvir 90mg + Sofobuvir 400mg.
• Follow your doctors orders exactly, including how much to take, any other drugs to be taken along with it, and when and how often to take it.
• Each tablet can be swallowed with a glass of water.

Adverse effects :

• Hepcinat-LP is generally well tolerated, with very few side effects and most of them mild and temporary.
• The most common side effects of Hepcinat-LP are headaches and tiredness.
• If you this you are having an allergic reaction to Hepcinat-LP, notify your doctor immediately. Signs may include rash, hives, excessive itching, unusual difficulty breathing, tightness in your chest, or swelling of the mouth, face, lips, or tongue resulting from the use of Hepcinat-LP.

Warnings

• You must not take Hepcinat-LP if you are allergic to ledipasvir or sofosbuvir or if you are already taking a medicine containing sofosbuvir.

• Before taking Hepcinat-LP you should advise your doctor of the following. Taking Hepcinat-LP in these cases could involve some risk or stop the medicine from working as intended :
  
  • If you are pregnant, planning to become pregnant, or are breast-feeding
  • If you are currently taking any prescription medicines, or non-prescription medicines (including herbal treatments and dietary supplements)
  • If you have had allergic reactions to medicines, foods, or other substances in the past
  • If you have kidney or liver problems

Some medicines can interact negatively with Hepcinat-LP :

• Simeprevir can increase the risk of ledipasvir and sofosbuvir's side effects
• Carbamazepine, oxcarbazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, St. John's wort, or tipranavir can decrease the effectiveness of ledipasvir and sofosbuvir
• The risk side effects of Digoxin or Rosuvastatin may be increased by the use of ledipasvir and sofosbuvir